1
|
Pavli A, Theodoridou M and Maltezou HC:
Post-COVID syndrome: Incidence, clinical spectrum, and challenges
for primary healthcare professionals. Arch Med Res. 52:575–581.
2021.PubMed/NCBI View Article : Google Scholar
|
2
|
Patient-led Research Collaborative:
Report: What does COVID-19 recovery actually look like? https://patientresearchcovid19.com/research/%20report-1/.
Accessed December 22, 2024.
|
3
|
O'Mahoney LL, Routen A, Gillies C, Ekezie
W, Welford A, Zhang A, Karamchandani U, Simms-Williams N, Cassambai
S, Ardavani A, et al: The prevalence and long-term health effects
of long COVID among hospitalized and non-hospitalized populations:
A systematic review and meta-analysis. EClinicalMedicine.
55(101762)2022.PubMed/NCBI View Article : Google Scholar
|
4
|
Davis HE, McCorkell L, Vogel JM and Topol
EJ: Long COVID: Major findings, mechanisms and recommendations. Nat
Rev Microbiol. 21:133–146. 2023.PubMed/NCBI View Article : Google Scholar
|
5
|
Nikolopoulou GB and Maltezou HC: COVID-19
in children: Where do we stand? Arch Med Res. 53:1–8.
2022.PubMed/NCBI View Article : Google Scholar
|
6
|
Maltezou HC, Magaziotou I, Dedoukou X,
Eleftheriou E, Raftopoulos V, Michos A, Lourida A, Panopoulou M,
Stamoulis K, Papaevangelou V, et al: Children and adolescents with
SARS-CoV-2 infection: Epidemiology, clinical course and viral
loads. Pediatr Infect Dis J. 39(e-388-3e92)2020.PubMed/NCBI View Article : Google Scholar
|
7
|
Maltezou HC, Vorou R, Papadima K,
Kossyvakis A, Spanakis N, Gioula G, Exindari M, Metallidis S,
Lourida AN, Raftopoulos V, et al: Transmission dynamics of
SARS-CoV-2 within families with children in Greece: A study of 23
clusters. J Med Virol. 93:1414–1420. 2021.PubMed/NCBI View Article : Google Scholar
|
8
|
Maltezou HC, Krumbholz B, Mavrouli M,
Tseroni M, Gamaletsou MN, Botsa E, Anastassopoulou C, Gikas A,
Fournarakou E, Kavieri M, et al: A study of the evolution of the
third COVID-19 pandemic wave in the Athens metropolitan area,
Greece, through two cross-sectional seroepidemiological surveys:
March, June 2021. J Med Virol. 94:1465–1472. 2022.PubMed/NCBI View Article : Google Scholar
|
9
|
Silva MMD, Benites MN, Castro YM, Moura PV
and Zhang L: Prevalence of symptoms of post-COVID-19 confition
(long COVID_ in children hospitalized with COVID-19: A systematic
review of observational studies. Pediatr Pulmonol. 59:3159–3169.
2024.PubMed/NCBI View Article : Google Scholar
|
10
|
Zheng YB, Zeng N, Yuan K, Tian SS, Yang
YB, Gao N, Chen X, Zhang AY, Kondratiuk AL, Shi PP, et al:
Prevalence and risk factor for long COVID in children and
adolescents: A meta-analysis and systematic review. J Infect Public
Health. 16:660–672. 2023.PubMed/NCBI View Article : Google Scholar
|
11
|
Mat Hassan N, Salim HS, Amaran S, Yunus
NI, Yusof NA, Daud N and Fry D: Prevalence of mental health
problems among children with long COVID: A systematic review and
meta-analysis. PLoS One. 18(e0282538)2023.PubMed/NCBI View Article : Google Scholar
|
12
|
Howe de la Torre S, Parlatini V and
Cortese S: Long-term certral nervous system (CNS) consequences of
COVID-19 in children. Expert Rev Neurother. 23:703–720.
2023.PubMed/NCBI View Article : Google Scholar
|
13
|
Morello R, Martino L and Buonsenso D:
Diagnosis and management of post-COVID (long COVID) in children: A
moving target. Curr Opin Pediatr. 35:184–192. 2023.PubMed/NCBI View Article : Google Scholar
|
14
|
Ha EK, Kim JH and Han YH: Long COVID in
children and adolescents: Prevalence, clinical manifestations, and
management strategies. Clin Exp Pediatr. 66:465–474.
2023.PubMed/NCBI View Article : Google Scholar
|
15
|
World Health Organization (WHO): A
clinical case definition for post COVID-19 condition in children
and adolescents by expert consensus, 16 February 2023. WHO, Geneva,
2023. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1.
Accessed December 22, 2024.
|
16
|
Maltezou HC, Pavli A and Tsakris A:
Post-COVID syndrome: An insight on its pathogenesis. Vaccines
(Basel). 9(497)2021.PubMed/NCBI View Article : Google Scholar
|
17
|
Yousaf AR, Mak J, Gwynn L, Bloodworth R,
Rai R, Jeddy Z, LeClair LB, Edwards L, Olsho LEW, Newes-Ideyi G, et
al: 1935. COVID-19 mRNA vaccination reduces the occurrence of
post-COVID conditions in U.S. children aged 5-17 years following
Omicron SARS-CoV-2 infection, July 2021-September 2022. Open Forum
Infect Dis. 10 (Suppl 2)(ofad500.2466)2023.
|
18
|
Camporesi A, Morello R, La Rocca A,
Zampino G, Vezzulli F, Munblit D, Raffaelli F, Valentini P and
Buonsenso D: Characteristics and predictors of long COVID in
children: A 3-year prospective cohort study. EClinicalMedicine.
76(102815)2024.PubMed/NCBI View Article : Google Scholar
|
19
|
Lokanuwatsatien T, Satdhabudha A,
Tangsathapornpong A, Bunjoungmanee P, Sinlapamongkolkul P,
Chaivakulsil C, Sritipsukho P and Tantiyavarong P: Prevalence and
associating factors of long COVID in pediatric patients during the
Delta and the Omicron variants. Front Pediatr.
11(1127582)2023.PubMed/NCBI View Article : Google Scholar
|
20
|
Maltezou HC, Hatziantoniou S, Theodoridou
K, Vasileiou K, Anastassopoulou C and Tsakris A: Anaphylaxis rates
following mRNA COVID-19 vaccination in children and adolescents:
Analysis of data reported to EudraVigilance. Vaccine. 41:2382–2386.
2023.PubMed/NCBI View Article : Google Scholar
|
21
|
Wu JY, Chen CC, Liu MY, Hsu WH, Tsai YW,
Liu TH, Pin-Chien S, Huang PY, Chuang MH, Lee MC, et al: Clinical
effectiveness of nirmatrelvir plus ritonavir on the short- and
long-term outcome in high-risk children with COVID-19. J Med Virol.
96(e29662)2024.PubMed/NCBI View Article : Google Scholar
|